Two more Roche biologics stolen, say Italian authorities
Vials of two Roche biologics have been stolen and distributed illegally from Italy, say authorities.
Vials of two Roche biologics have been stolen and distributed illegally from Italy, say authorities.
Oncology development company Celsion will acquire Egen, a biotech company that is developing nucleic acid-based therapeutics, for $14m upfront, with the chance for more than $30m in milestone payments.
Lonza has invested in single-use technology at its Swiss clinical manufacturing facility citing a rise in demand as customer’s grow their antibody-drug conjugate (ADC) pipelines.